Migraine Drugs Market Size & Share Report 2023-2028 {{ currentPage ? currentPage.title : "" }}

IMARC Group, a leading market research company, has recently releases report titled “Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global migraine drugs market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the migraine drugs market?

Report Attributes

Details

Market Size in 2022

US$ 4.0 Billion

Market Forecast in 2028

US$ 5.4 Billion

Growth rate (2023 to 2028)

CAGR of 4.5%

Base Year of the Analysis

2022

Forecast Period

2023-2028

What are migraine drugs?

Migraine drugs refer to medications that are used to reduce the severity of migraines and prevent future attacks. A migraine is a severe, neurological disease with a debilitating headache, characterized by an intense throbbing or pulsing in one area of the head. It is accompanied by sensitivity to light, sound and smell, visual disturbances such as auras, and nausea or vomiting. Migraine drugs do not cure migraines; instead, they treat or relieve these symptoms. There are certain blood pressure medications, as well as some antidepressants, anti-seizure drugs and herbals that are used to reduce the frequency of migraines.

Request for a free sample copy of this report: https://www.imarcgroup.com/migraine-drugs-market/requestsample

What are the growth prospects and trends in the migraine drugs industry?

According to the Migraine Trust, migraine is the third most common disease globally, with more than 10% of people getting affected by the condition worldwide. This represents the primary factor that has increased the demand for migraine drugs across the globe. Apart from this, the rising healthcare expenditure and improving reimbursement policies for migraine medications are also acting as growth-inducing factors. Besides this, healthcare providers have made significant advancements in the diagnosis and treatment of migraine. A more advanced treatment modality with mechanism-based therapies, including supraorbital transcutaneous stimulation (STS) and transcranial magnetic stimulation, has been introduced as a preventive therapy for migraine. Additionally, there are many other drugs with novel mechanisms of action or new therapeutic targets, which are in different development stages.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Treatment Type:

  • Abortive Treatment

  • Preventive Treatment

Breakup by Drug Type:

  • Triptans

  • Ergot Alkaloids

  • NSAIDs

  • Acetylcholine Inhibitors/ Neurotoxins

  • Ditans

  • CGRP mAbs

  • Others

Breakup by Route of Administration:

  • Oral

  • Injectable

  • Others

Breakup by Distribution Channel:

  • Hospital-Based Pharmacies

  • Retail Pharmacies

  • Others

Breakup by Region:

  • North America: (United States, Canada)

  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)

  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)

  • Latin America: (Brazil, Mexico, Others)

  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories

  • Allergan Plc (Abbvie Inc.)

  • Amgen Inc.

  • AstraZeneca Plc

  • Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)

  • Eisai Co. Ltd.

  • Eli Lilly and Company

  • Endo International Plc

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Merck & Co.

  • Novartis AG

  • Pfizer Inc.

  • Sanofi SA

  • Teva Pharmaceutical Industries Limited.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2543&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

{{{ content }}}